Previous 10 | Next 10 |
This article is part of a series that provides an ongoing analysis of the changes made to Larry Robbins’ 13F portfolio on a quarterly basis. It is based on Robbins’ regulatory 13F Form filed on 11/14/2019. Please visit our Tracking Larry Robbins’ Glenview Capital Manage...
by Daniel Shvartsman Listen to or subscribe to Behind the Idea on these podcast platforms: iTunes/Apple Podcasts Spotify Stitcher The waiting is the hardest part, as Tom Petty sang. That rings true this time of year, where the holiday season has been around...
This article is part of a series that provides an ongoing analysis of the changes made to Berkshire Hathaway's 13F stock portfolio on a quarterly basis. It is based on Warren Buffett's regulatory 13F Form filed on 11/14/2019. Please visit our Tracking 10 Years Of Berkshire Hathaway's Invest...
Last week, DaVita ( DVA ) released its Q3/19 results ( call transcript ) and enjoyed a rare rally, presumably mostly because of short covering. It has been a battleground stock for some time and expectations were low. With its Q3 results DaVita managed to outperform market expectations, as...
On Nov. 8, FibroGen (NASDAQ: FGEN) and its partner AstraZeneca (NYSE: AZN) reported safety and efficacy data from a pooled analysis of six large phase 3 clinical trials with roxadustat, a drug aimed at treating anemia in patients with chronic kidney disease (CKD). In the non-dialys...
Stocks finished Wednesday's session close to where they started, with major market benchmarks getting pushed and pulled by conflicting readings on the health of the U.S. economy and the 10-year-old bull market. Investors seem to be waiting for some positive catalyst to send indexes further into ...
DaVita Inc. (DVA) Q3 2019 Earnings Conference Call November 05, 2019 05:00 PM ET Company Participants Jim Gustafson - Vice President, Investor Relations Javier Rodriguez - Chief Executive Officer Joel Ackerman - Chief Financial Officer LeAnne Zumwalt - Group Vice President Ji...
DaVita (NYSE: DVA ) Q3 results : More news on: DaVita Inc., Healthcare stocks news, Earnings news and commentary, Stocks on the move, Read more ...
DaVita HealthCare Partners (NYSE: DVA ): Q3 Non-GAAP EPS of $1.53 beats by $0.29 ; GAAP EPS of $0.99 misses by $0.23 . Revenue of $2.9B (+1.8% Y/Y) beats by $50M . Shares +6.9% . Press Release More news on: DaVita Inc., Earnings news and commentary, Stocks on the move, Healthca...
DENVER , Nov. 5, 2019 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) today announced results for the quarter ended September 30, 2019. Third quarter 2019 financial and operational highlights: Consolidated revenues of $2.904 billion . Operating income of $378 million and adj...
News, Short Squeeze, Breakout and More Instantly...
DaVita Inc. Schedules 2nd Quarter 2024 Investor Conference Call PR Newswire DENVER , July 18, 2024 /PRNewswire/ -- DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss second quarter results on Tuesday, Aug...
2024-06-21 02:20:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...